Raffa Robert B, Pergolizzi Joseph V
Temple University School of Pharmacy, Philadelphia, PA 19401, USA.
Pain Manag Nurs. 2013 Sep;14(3):e67-83. doi: 10.1016/j.pmn.2011.04.002. Epub 2011 Jun 25.
There is a curious and paradoxic phenomenon, reliably demonstrated in animal models, that consists of an increased sensitivity to pain that is apparently induced by the very opioid drugs used to ameliorate the pain. This phenomenon is termed "opioid-induced hyperalgesia." Whether opioid-induced hyperalgesia occurs in humans, and, if so, to what extent and consequence, is far less established. This is a critical question for attempting to treat pain. If opioid-induced hyperalgesia develops in a patient, it would masquerade as tolerance (because the clinical effectiveness of the opioid would be diminished), yet the appropriate clinical adjustment would be precisely the opposite to that of tolerance. It would be to decrease, rather than increase, the dose of opioid. We review the evidence, particularly the clinical evidence, about opioid-induced hyperalgesia and the postulated mechanisms. We conclude that given the clinical ramifications, opioid-induced hyperalgesia is one of the most understudied important aspects of opioid research.
有一种奇特且矛盾的现象,在动物模型中得到了可靠证实,即对疼痛的敏感性增加,而这种增加显然是由用于缓解疼痛的阿片类药物所诱发的。这种现象被称为“阿片类药物诱导的痛觉过敏”。阿片类药物诱导的痛觉过敏是否会在人类身上发生,以及如果发生,其程度和后果如何,目前还远未明确。这是试图治疗疼痛时的一个关键问题。如果患者出现阿片类药物诱导的痛觉过敏,它会伪装成耐受性(因为阿片类药物的临床疗效会降低),然而适当的临床调整却与耐受性的调整恰恰相反。应该减少而非增加阿片类药物的剂量。我们回顾了关于阿片类药物诱导的痛觉过敏及其假定机制的证据,尤其是临床证据。我们得出结论,鉴于其临床影响,阿片类药物诱导的痛觉过敏是阿片类药物研究中研究最少的重要方面之一。